Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (4027)
All Articles published online
|
Publishing Process of This Article
|
Nov 26, 2020 (publication date) through Apr 19, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Clinical Cases
ISSN
2307-8960
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Ma YY, Leng Y, Xing YL, Li HM, Chen JB, Niu LZ. Gemcitabine plus concurrent irreversible electroporation vs gemcitabine alone for locally advanced pancreatic cancer. World J Clin Cases 2020; 8(22): 5564-5575 [PMID: 33344547 DOI: 10.12998/wjcc.v8.i22.5564] |
|---|---|
| URL: | https://www.wjgnet.com/2307-8960/full/v8/i22/5564.htm |
| Number | Citing Articles |
| 1 |
Yangyang Ma, Yanli Xing, Hongmei Li, Ting Yuan, Bing Liang, Rongrong Li, Jianyu Li, Zhonghai Li, Shuying Li, Lizhi Niu. Irreversible electroporation combined with chemotherapy and PD-1/PD-L1 blockade enhanced antitumor immunity for locally advanced pancreatic cancer. Frontiers in Immunology 2023; 14 doi: 10.3389/fimmu.2023.1193040
|
| 2 |
Zainab L Rai, Veronica Ranieri, Daniel H Palmer, Peter Littler, Pauleh Ghaneh, Kurinchi Gurusamy, Derek Manas, Elena Pizzo, Eftychia Eirini Psarelli, Roopinder Gilmore, Praveen Peddu, David C Bartlett, Nicola de Liguori Carino, Brian R Davidson. Treatment of unresectable locally advanced pancreatic cancer with percutaneous irreversible electroporation (IRE) following initial systemic chemotherapy (LAP-PIE) trial: study protocol for a feasibility randomised controlled trial. BMJ Open 2022; 12(5): e050166 doi: 10.1136/bmjopen-2021-050166
|
| 3 |
Agnieszka Gajewska-Naryniecka, Urszula Szwedowicz, Zofia Łapińska, Julia Rudno-Rudzińska, Wojciech Kielan, Julita Kulbacka. Irreversible Electroporation in Pancreatic Cancer—An Evolving Experimental and Clinical Method. International Journal of Molecular Sciences 2023; 24(5): 4381 doi: 10.3390/ijms24054381
|
| 4 |
Yangyang Ma, Yanli Xing, Hongmei Li, Bing Liang, Rongrong Li, Jianyu Li, Zhonghai Li, Mao Lin, Lizhi Niu, Jinghua Pan. Simultaneous Gemcitabine and Percutaneous CT-Guided Irreversible Electroporation for Locally Advanced Pancreatic Cancer. Journal of Oncology 2022; 2022: 1 doi: 10.1155/2022/3523769
|
| 5 |
Andras Bibok, Dae Won Kim, Mokenge Malafa, Bela Kis. Minimally invasive image-guided therapy of primary and metastatic pancreatic cancer. World Journal of Gastroenterology 2021; 27(27): 4322-4341 doi: 10.3748/wjg.v27.i27.4322
|
| 6 |
Thomas Lambin, Cyril Lafon, Robert Andrew Drainville, Mathieu Pioche, Frédéric Prat. Locoregional therapies and their effects on the tumoral microenvironment of pancreatic ductal adenocarcinoma. World Journal of Gastroenterology 2022; 28(13): 1288-1303 doi: 10.3748/wjg.v28.i13.1288
|
| 7 |
Florentine E F Timmer, Bart Geboers, Alette H Ruarus, Laurien G P H Vroomen, Evelien A C Schouten, Susan van der Lei, Danielle J W Vos, Madelon Dijkstra, Hannah H Schulz, Joyce Bakker, Bente A T van den Bemd, Petrousjka M van den Tol, Robbert S Puijk, Birgit I Lissenberg-Witte, Tanja D de Gruijl, Jan J J de Vries, Frank J Lagerwaard, Hester J Scheffer, Anna M E Bruynzeel, Martijn R Meijerink. MRI-guided stereotactic ablative body radiotherapy versus CT-guided percutaneous irreversible electroporation for locally advanced pancreatic cancer (CROSSFIRE): a single-centre, open-label, randomised phase 2 trial. The Lancet Gastroenterology & Hepatology 2024; 9(5): 448 doi: 10.1016/S2468-1253(24)00017-7
|